Background The impact of body composition (BC) abnormalities on COVID-19 outcomes
remains to be determined. Objectives We summarized the evidence on BC abnormalities …

Abstract Coronavirus disease 2019 (COVID-19) spread rapidly and became a severe global
public health threat. Older adults have a high risk of COVID-19 and its associated mortality …

Background Chronic disease causes skeletal muscle loss that contributes to morbidity and
mortality. There are limited data on the impact of dynamic muscle loss on clinical outcomes …

Rationale and Objectives To evaluate the impact of low skeletal muscle mass in patients
with COVID-19 on relevant outcomes like 30-day mortality, need for intubation and need for …

Background The duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) RNA positivity will be important to prevent the spread of coronavirus disease 2019 …

Introduction Body composition (BC) assessment can supply accurate information for in-
hospital nutritional evaluation. The aim of this study was to explore in the literature how the …

Background COVID-19 has demonstrated a highly variable disease course, from
asymptomatic to severe illness and eventually death. Clinical parameters, as included in the …

Background/Aim: The effect of sarcopenia on patients with severe Covid-19 disease is
unknown. We aimed to assess the influence of baseline computed tomography (CT)-based …

Background Community-acquired pneumonia (CAP) causes high morbidity and mortality in
all age groups worldwide. Lower muscle radiodensity was associated with worse clinical …

Background Sarcopenia, or skeletal muscle depletion, was common in the elderly and often
led to a poor prognosis of diseases. The area of the psoas muscle in abdominal computed …